New insights into the role of IL-17 in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 16, Issue 12, 2010, Pages 2180-2181

  Noronha, Ansu Mammen ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; INTERFERON ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 17;

ENTERITIS; HUMAN; IMMUNOPATHOGENESIS; INTROSPECTION; LAMINA PROPRIA; MONONUCLEAR CELL; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; TH1 CELL; TH17 CELL;

EID: 78649586397     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21333     Document Type: Note

References (4)

1. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003; 52: 65-70. (Pubitemid 36020767)
2. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17. J Exp Med. 2007; 204: 1849-1861.
3. Kobayashi T, Okamoto S, Hisamatsu T, et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut. 2008; 57: 1682-1689.
4. Fantini MC, Monteleone G, MacDonald TT,. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 2008; 1: 110-115.